Measuring and using light in the melanopsin age
- PMID: 24287308
- PMCID: PMC4699304
- DOI: 10.1016/j.tins.2013.10.004
Measuring and using light in the melanopsin age
Abstract
Light is a potent stimulus for regulating circadian, hormonal, and behavioral systems. In addition, light therapy is effective for certain affective disorders, sleep problems, and circadian rhythm disruption. These biological and behavioral effects of light are influenced by a distinct photoreceptor in the eye, melanopsin-containing intrinsically photosensitive retinal ganglion cells (ipRGCs), in addition to conventional rods and cones. We summarize the neurophysiology of this newly described sensory pathway and consider implications for the measurement, production, and application of light. A new light-measurement strategy taking account of the complex photoreceptive inputs to these non-visual responses is proposed for use by researchers, and simple suggestions for artificial/architectural lighting are provided for regulatory authorities, lighting manufacturers, designers, and engineers.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Of the 14 authors on this manuscript, Drs. Berson, Cooper, Gamlin, Price, Provencio, and O’Hagan identify no potential conflicts of interest related to the manuscript, developed from the First International Workshop on Circadian and Neurophysiological Photometry. Dr. Brainard reports that through Thomas Jefferson University, his laboratory has received equipment, advice or financial support from the IESNA Philadelphia Chapter; Panasonic, OSRAM-Sylvania, Philips Lighting; Lutron, Lighting Sciences Group, Apollo Lighting; BioBrite Inc., and Litebook, and he holds two currently issued patents (USPTO#09/853,428 and # 8,366,755) and two continuing patent applications (USPTO#09/853,428 and World PCT 2005/004948AZ). Dr. Brown reports that he is currently contributing to a project funded by Philips Lighting and has received funding from Philips Lighting previously. Dr. Czeisler reports that he has received consulting fees from or served as a paid member of scientific advisory boards for a number of companies such as: Cephalon, Inc. (acquired by Teva Pharmaceutical Industries Ltd.); Koninklijke Philips Electronics, N.V.; Sleep Multimedia, Inc.; and Zeo, Inc.; owns equity interests or receives royalties from other companies such as Philips Respironics, Inc.; is the incumbent of an endowed professorship provided to Harvard University by Cephalon, Inc.; holds a number of process patents in the field of sleep/circadian rhythms (e.g., photic resetting of the human circadian pacemaker), has served as an expert witness on various legal cases related to sleep and/or circadian rhythms; and directs the Harvard Medical School Division of Sleep Medicine, which has received unrestricted research and educational gifts and endowment funds from companies such as Philips Respironics, Inc. and Cephalon, Inc. Dr. Figueiro reports that the Lighting Research Center receives funding from GE Lighting, Philips Lighting, Philips Respironics, OSRAM Sylvania, and has built a light meter used for collecting circadian light in the field. Dr. Lockley reports having received consulting fees from a number of companies such as Apollo Lighting, Naturebright; unrestricted equipment gifts from Bioilluminations LLC, Bionetics Corporation, Philips Lighting; a fellowship gift from Optalert in Australia; honoraria, travel, accommodation and/or meals for invited presentations or teaching from companies such as Velux, Apollo Lighting, Illinois Coalition for Responsible Outdoor Lighting, Lighting Science Group Corp, and Philips Lighting; has completed or ongoing research grants from Alcon Inc, Apollo Lighting, Illuminations LLC, and Philips Lighting; has received patent revenue from a patent assigned to the University of Surrey; and holds a pending patent assigned to the Brigham and Women’s Hospital. Dr. Lucas reports receiving project awards from Philips Lighting. Dr. Peirson reports that his laboratory has a postdoctoral fellowship sponsored by Roche. Dr. Skene reports having a patent (PHNL000507WO; EP 1317302B1); being the beneficiary of an agreement between the University of Surrey and Philips Lighting B.V. for patent assignment and receiving research grant support; receiving grant support from Philips Consumer Lifestyle B.V.; and being Co-director of Stockgrand Ltd., UK.
Figures
References
-
- Aschoff J. Handbook of behavioral neurobiology No. 4: Biological rhythms. New York: Plenum; 1981.
-
- Wurtman RJ, Baum MJ, Potts J. The Medical and Biological Effects of Light. New York: The New York Academy of Sciences; 1985.
-
- Wetterberg L. Light and Biological Rhythms in Man. Stockholm: Pergamon Press; 1993.
-
- Lam RW. Beyond seasonal affective disorder: Light treatment for SAD and non-SAD disorders. Wasington, D.C.: American Psychiatric Press, Inc; 1996.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
